ESR1 and breast carcinoma: Therefore, for the present study, we established a cohort of 116 patients afflicted with triple-negative breast cancer (TNBC), which accounts for approximately 10–15% of all breast cancers and is defined by the absence of estrogen receptor (ER), progesterone receptor (PR), and HER2 overexpression.